ELIZABETH NEWMAN: Open Payments
NPI 1518457035 · GAINESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 32 payments from 14 companies in 2025. Trend: 2023 $163 · 2024 $362 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $100 |
| Sage Therapeutics, LLC | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, ZURZUVAE, Exparel, VOQUEZNA, Mirena, BREZTRI, OTEZLA.
Industry payments across TX — which companies pay providers there.
